Imunon, Inc. Increase (Decrease) in Other Accrued Liabilities
Imunon, Inc. (IMNN) reported Increase (Decrease) in Other Accrued Liabilities of $1.07 million for the 12-month period ending 2022-12-31, per its 10-K filed 2023-03-30.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherAccruedLiabilities · last filed 2023-03-30
- Imunon, Inc. increase (decrease) in other accrued liabilities for the quarter ending 2014-12-31 was $681.22K, a 48.14% decline year-over-year.
- Imunon, Inc. increase (decrease) in other accrued liabilities for the quarter ending 2014-09-30 was -$97.97K.
- Imunon, Inc. increase (decrease) in other accrued liabilities for the quarter ending 2014-06-30 was -$332.72K, a 145.55% decline year-over-year.
- Imunon, Inc. increase (decrease) in other accrued liabilities for the quarter ending 2014-03-31 was -$501.81K.
- Imunon, Inc. increase (decrease) in other accrued liabilities for fiscal 2022 was $1.07M, a 333.97% increase from fiscal 2021.
- Imunon, Inc. increase (decrease) in other accrued liabilities for fiscal 2021 was $247.14K, a 7.05% decline from fiscal 2020.
- Imunon, Inc. increase (decrease) in other accrued liabilities for fiscal 2020 was $265.88K.
- Imunon, Inc. increase (decrease) in other accrued liabilities for fiscal 2019 was -$611.75K, a 301.85% decline from fiscal 2018.
| Period end | Increase (Decrease) in Other Accrued Liabilities 3 month | Increase (Decrease) in Other Accrued Liabilities 6 month | Increase (Decrease) in Other Accrued Liabilities 9 month | Increase (Decrease) in Other Accrued Liabilities 12 month |
|---|---|---|---|---|
| 2022-12-31 | $1.07M 10-K · filed 2023-03-30 | |||
| 2021-12-31 | $247.14K 10-K · filed 2023-03-30 | |||
| 2020-12-31 | $265.88K 10-K · filed 2022-03-31 | |||
| 2019-12-31 | -$611.75K 10-K · filed 2021-03-19 | |||
| 2018-12-31 | $303.07K 10-K · filed 2020-03-25 | |||
| 2017-12-31 | -$200.93K 10-K · filed 2019-03-29 | |||
| 2016-12-31 | $563.99K 10-K · filed 2018-03-27 | |||
| 2015-12-31 | -$536.60K 10-K · filed 2017-03-24 | |||
| 2014-12-31 | $681.22K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-30 | $583.25K derived: sum of 2 quarters · filed 2016-03-30 | $250.53K derived: sum of 3 quarters · filed 2016-03-30 | -$251.29K 10-K · filed 2016-03-30 |
| 2014-09-30 | -$97.97K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-10 | -$430.69K derived: sum of 2 quarters · filed 2014-11-10 | -$932.50K 10-Q · filed 2014-11-10 | $381.03K derived: sum of 4 quarters · filed 2016-03-30 |
| 2014-06-30 | -$332.72K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-07 | -$834.53K 10-Q · filed 2014-08-07 | $479.00K derived: sum of 3 quarters · filed 2016-03-30 | $90.15K derived: sum of 4 quarters · filed 2016-03-30 |
| 2014-03-31 | -$501.81K 10-Q · filed 2014-05-08 | $811.72K derived: sum of 2 quarters · filed 2016-03-30 | $422.87K derived: sum of 3 quarters · filed 2016-03-30 | $1.15M derived: sum of 4 quarters · filed 2016-03-30 |
| 2013-12-31 | $1.31M derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-30 | $924.69K derived: sum of 2 quarters · filed 2016-03-30 | $1.66M derived: sum of 3 quarters · filed 2016-03-30 | $1.50M 10-K · filed 2016-03-30 |
| 2013-09-30 | -$388.85K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-10 | $341.57K derived: sum of 2 quarters · filed 2014-11-10 | $184.03K 10-Q · filed 2014-11-10 | -$1.28M derived: sum of 4 quarters · filed 2015-03-12 |
| 2013-06-30 | $730.41K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-07 | $572.88K 10-Q · filed 2014-08-07 | -$887.65K derived: sum of 3 quarters · filed 2015-03-12 | -$62.55K derived: sum of 4 quarters · filed 2015-03-12 |
| 2013-03-31 | -$157.53K 10-Q · filed 2014-05-08 | -$1.62M derived: sum of 2 quarters · filed 2015-03-12 | -$792.97K derived: sum of 3 quarters · filed 2015-03-12 | -$1.51M derived: sum of 4 quarters · filed 2015-03-12 |
| 2012-12-31 | -$1.46M derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-12 | -$635.43K derived: sum of 2 quarters · filed 2015-03-12 | -$1.36M derived: sum of 3 quarters · filed 2015-03-12 | -$776.96K 10-K · filed 2015-03-12 |
| 2012-09-30 | $825.10K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-12 | $104.25K derived: sum of 2 quarters · filed 2013-11-12 | $683.58K 10-Q · filed 2013-11-12 | $938.74K derived: sum of 4 quarters · filed 2014-03-13 |
| 2012-06-30 | -$720.85K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-08 | -$141.52K 10-Q · filed 2013-08-08 | $113.64K derived: sum of 3 quarters · filed 2014-03-13 | $202.40K derived: sum of 4 quarters · filed 2014-03-13 |
| 2012-03-31 | $579.32K 10-Q · filed 2013-05-09 | $834.49K derived: sum of 2 quarters · filed 2014-03-13 | $923.25K derived: sum of 3 quarters · filed 2014-03-13 | -$811.84K derived: sum of 4 quarters · filed 2014-03-13 |
| 2011-12-31 | $255.17K derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-13 | $343.93K derived: sum of 2 quarters · filed 2014-03-13 | -$1.39M derived: sum of 3 quarters · filed 2014-03-13 | -$92.25K 10-K · filed 2014-03-13 |
| 2011-09-30 | $88.76K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-09 | -$1.65M derived: sum of 2 quarters · filed 2012-11-09 | -$347.42K 10-Q · filed 2012-11-09 | -$209.13K derived: sum of 4 quarters · filed 2013-03-18 |
| 2011-06-30 | -$1.74M derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-14 | -$436.18K 10-Q · filed 2012-08-14 | -$297.89K derived: sum of 3 quarters · filed 2013-03-18 | $213.86K derived: sum of 4 quarters · filed 2013-03-18 |
| 2011-03-31 | $1.30M 10-Q · filed 2012-05-15 | $1.44M derived: sum of 2 quarters · filed 2013-03-18 | $1.95M derived: sum of 3 quarters · filed 2013-03-18 | |
| 2010-12-31 | $138.29K derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-18 | $650.04K derived: sum of 2 quarters · filed 2013-03-18 | $655.70K 10-K · filed 2013-03-18 | |
| 2010-09-30 | $511.75K derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-10 | $517.41K 10-Q · filed 2011-11-10 | ||
| 2010-06-30 | $5.66K 10-Q · filed 2011-08-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SOLIGENIX, INC. (SNGX) | United States | $0.008B | |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |
| Traws Pharma, Inc. (TRAW) | United States | $0.009B | -0.58 |
| Alzamend Neuro, Inc. (ALZN) | United States | $0.009B | |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| FibroBiologics, Inc. (FBLG) | United States | $0.009B | -0.27 |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |